Ser75
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.6.0.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser75  -  Myt1 (starfish)

Site Information
ESRPRAVsFRQSEPS   SwissProt
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 449752

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , phosphopeptide mapping ( 1 )
Relevant cell line - cell type - tissue:
oocyte [CPEB (mouse)] ( 1 )

Upstream Regulation
Putative in vivo kinases:
Akt1 (human) ( 1 )
Kinases, in vitro:
Akt1 (human) ( 1 )
Treatments:
1-methyladenine ( 1 )

Downstream Regulation
Effects of modification on Myt1:
activity, inhibited ( 1 )
Effects of modification on biological processes:
cell cycle regulation ( 1 )

References 

1

Okumura E, et al. (2002) Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat Cell Biol 4, 111-6
11802161   Curated Info